20th April 2018 Content supplied by: QIAGEN Benelux B.V.
QIAGEN Launches QIAstat-Dx® in Europe
QIAGEN have announced the European launch of QIAstat-Dx, the next generation of advanced multiplex syndromic testing, which enables laboratory technicians to accurately diagnose a range of syndromes in infections, oncology and other disease areas.
Its flexible system design enables the accurate identification of clinical samples to deliver valuable insights into the exact cause of various syndromes, including respiratory or gastrointestinal infections. The entire process can be completed in up to an hour.
Visit QIAGEN at booth #36 to learn more about QIAstat-Dx or hear daily booth talks from experts on their focus, ‘See Disease Differently from Sample to Insight’.
Date Published: 20th April 2018
Source article link: View
Microbank™ - Original Long Term
Bruker Introduces Bologna Workflow for